Deletion of components ~100 kDa, and subsequently ~10 kDa, reduced alveolar cross-sectional area by 70% to 22-25 X lo3 um2: the approximate size of alveolar-like structures formed on purified laminin-1 alone. The deleted basement membrane material was adhesive for type II alveolar cells but failed to support alveolar formation in the absence of laminin-1. Preincubation of basement membrane with neutralizing anti-epidermal growth factor (EGF), -basic fibroblast growth factor (bFGF), -insulin-like growth factor (IGF)II, or -transforming growth factor (TGF)-l3 antibodies had no inhibitory effect. Because both subtracted basement membrane preparations have in common the exclusion of components ~10 kDa, these results are interpreted as pointing to a sub-lo-kDa alveolarization activity (s) that plays a key accessory role in laminin-ldependent alveolar formation. extracellular matrix; alveoli; development; laminin MORPHOGENESIS OF LUNG ALVEOLI is a Complex process Of epithelial outgrowth, proliferation, migration, differentiation, and assembly (9) that proceeds in a dynamic state of cellular adherence to the nascent alveolar basement membrane (20) . Historically considered as an inactive and amorphous carbohydrate coating, the alveolar basement membrane is now known to be a supportive, pliable gel to which types I and II alveolar cells gain adherence through integrin receptors (6,16). The alveolar basement membrane is rich in laminin-1 (11, 17), a large cell adhesion glycoprotein that is synthesized by type II alveolar cells (9). Before or after exocytosis from the basal cell surface, laminin-1 complexes with itself (32) and with collagen IV, with perlecan (18), and indirectly with transforming growth factor (TGF)-P (23), basic fib ro as growth factor (bFGF) (4), and bl t other components, both characterized and unknown, to give rise to an insoluble extracellular sheet that may exist in a constant state of replenishment and subtle compositional alteration (10,20).
Functional implications of the alveolar cell-basement membrane adhesion complex have focused on the type II alveolar cell, the proliferative progenitor of attenuated type I alveolar cells (21>, which serves as the sole source of pulmonary surfactant (15) and whose cuboida1 shape lends itself to isolation for primary culture (24). Such studies have revealed the adhesion complex to be the primary requirement for type II alveolar cell differentiation (9>, and under appropriate conditions to promote an in vitro "alveolarization" in which type II alveolar cells migrate together into three-dimensional alveolar-like structures (1, 3, 12) with similarities in size and structure to fetal alveoli. This latter process has been used as a model system (22) that, despite limitations associated with simplification, offers an opportunity to precisely define active molecules whose relevance in vivo may later be inferred by immunohistochemical analysis. Systematic examination of basement membrane fractions, followed by use of antibodies and synthetic peptides, recently allowed us to localize a key alveolarization activity to amino acids 2179-2198 in the carboxy terminal region of the laminin-1 a-chain (22). Here we report the existence of an accessory alveolarization activity in a novel lower-molecularweight cell adhesive fraction of basement membrane. Peak 2 failed to form an adequate gel, but was nonetheless assayed for alveolarization activity. Serumcontaining plating medium was DMEM containing 10% fetal bovine serum. Serum-free plating medium was Eagle's minimum essential medium containing insulin (5 ug/ml), transferrin (50 ug/ml), sodium selenite (0.5 rig/ml), biotin (10 rig/ml), and supplemental nonessential amino acids. Gelled substrates were prepared by preincubation for 1 h at 37°C as previously described (22). In antibody experiments, gelled BMS was incubated with experimental antibody (as purified monoclonal antibody at 10 ug/well) for 1 h at 37°C and washed two times with medium before addition of cells.
METHODS

Preparation
Alveolar formation was monitored at 24-h intervals over 4 days from photographic negatives ( x 4 original magnification of the central portion of each well) of triplicate wells. Images enlarged five times were projected onto a grid (individual grid size: 0.5 X 0.5 cm; or alternatively printed onto photographic paper, followed by grid overlay). Area of all cellular structures falling under intersecting lines of the grid was determined by manual tracing on a MacIntizer Digitizing tablet (GTCO; Columbia MD).
Cell adhesion assay. Adhesion to peak 2 by freshly isolated type II alveolar cells was examined by the crystal violet detection method, as previously detailed (22 
RESULTS
Freshly isolated type II alveolar cells readily adhere to BMS, a 10 mM EDTA extract of mouse EHS tumor basement membrane, and assemble into alveoli-like structures over several days (Figs. 1 and 2) in a proliferation-independent manner (22). Morphogenesis was serum-enhanced but not dependent (Fig. 1, A and  B) and required an underlying basement membrane. Use of collagen I (22) or plastic (Fig. 1, A and B) was completely without effect.
Previous studies established that laminin-1, a major high-molecular-weight component of alveolar basement membranes, plays an important role in this process (22). Basement membrane is a mixture of numerous components both characterized and unknown. To ask whether lower-molecular-weight components are contributory and whether extracellular calcium is required (Figs. 2  and 3 ), we prepared BMS deficient in components ~100 kDa (BMS-loo), or lacking components < 10 kDa (BMS-10). We also examined alveolar formation in the presence of calcium-free medium. Both BMS-100 (Fig. 2B ) and BMS-10 ( Fig. 2C) were active, but alveoli were considerably smaller (22-25 x lo3 um2; Fig. 3 ) than those formed on intact BMS (70 X lo3 um2; Figs. 2A and  3) . Alveolar formation was also calcium dependent (Figs. 20 and 3 ) and in calcium-free cultures could be initiated by adding calcium on days 2 or 3 (not shown). Because both subtracted BMS preparations contain laminin-1 but exclude components ~10 kDa, it appears that a supplemental alveolarization activity resides in the sub-10 kDa range, and that combination of this activity with laminin-1 is likely required for the development of full-size alveoli.
To pursue the nature of the lower-molecular-weight activity(s) (Fig. 4) , BMS was separated into high (laminin-entactin rich; peak 1>-and low-molecular-weight (peak 2) peaks by gel filtration (Fig. 4A, inset) . The uncharacterized low-molecular-weight peak (Fig. 4A was tested for cell adhesion and alveolarization activity. For analysis of cell adhesion, fractions through this peak were pooled in groups of ten. Fractions 5-7, consisting mainly of OD 280-detectable material 512.4 kDa (Fig. 4A) , supported type II alveolar cell adhesion at levels similar to laminin-1 (Fig. 4B) . In alveolarization assays peak 2 failed to form an adequate threedimensional gel and was inactive (Fig. 4B, inset) , much like thin gels or monolayers of laminin-1, which also fail to support alveolar formation (Matter and Laurie, unpublished observations). Could the putative activity(s) be attributable to a growth factor(s) that may be resident in BMS? bFGF (17.5 kDa) is known to be associated with alveolar basement membranes (25) and is also likely to be present in BMS. In addition, EGF (6.1 kDa) but not TGF-P (25 kDa) stimulates type II alveolar cell differentiation (31); and IGFII (8.7 kDa) can be readily detected in developing lung (2, 29). To examine this possibility, neutralizing anti-growth factor antibodies, including anti-EGF, -bFGF, -1GFI1, and -TGF-l3, were preincubated with gelled BMS (Fig. 5) . Unbound antibody was washed away, and freshly isolated type II alveolar cells were plated in serum-free medium. None of the antibodies was inhibitory (Fig. 5) .
DISCUSSION
Development of lung alveoli is an elaborate process for which interactions between the alveolar cell and the alveolar basement membrane appear to play an important role. Subtraction of lower-molecular-weight components from basement membrane has led in this study to the tentative identification of a sub-lo-kDa activity(s) with a key accessory role in alveolar formation in vitro.
We took advantage of the observation that gelled BMS (22) or Matrigel(l,3, 12), triggered the assembly of isolated type II alveolar cells into alveoli-like structures in vitro. Functional dissection of BMS previously identified a novel alveolar-promoting site within amino acids 2179-2198 (SN-peptide) of the laminin-1 a-chain, a laminin isoform enriched in alveolar basement membranes (22). The possible presence of additional alveolarization activities was pursued by plating type II alveolar cells on BMS depleted of components ~100 kDa (BMS-100) or 10 kDa (BMS-10). Alveolar size was equally reduced by 70%, thereby pointing to a shared sub-lo-kDa activity(s) coincident with a previously undescribed type II alveolar cell adhesion factor(s) in this size range. Alveolar formation was not inhibited by neutralizing anti-EGF, bFGF, IGF-II, or TGF-P antibodies.
What is the nature of the sub-lo-kDa activity(s Although not yet examined in lung alveolar formation, E-cadherin is expressed by lung alveolar cells in vivo (27) and plays a key role in alveolar formation by basement membrane adherent mammary epithelial cells in vitro (8), a process which is altered by manipulations that inhibit or reduce E-cadherin expression by these cells (8). Moreover, E-cadherin is necessary for the polarization and differentiation of a number of different cells (14).
In summary, functional dissection of basement membrane using an in vitro model system for lung alveolar formation suggests the presence of a sub-lo-kDa activity(s) that may play a key accessory role in laminin-ldependent alveolar formation.
This putative activity(s) 1) appears not to be EGF, bFGF, IGF-II, TGF-P, or HGF; 2) is associated with a cell adhesion activity possibly of similar size; and 3) may require insolubilization in a three-dimensional gelled matrix for activity. In the absence of a suitable reconstitution assay, this activity(s) may be best pursued by preparation of neutralizing antibodies.
